Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
NCT06094478 · View on ClinicalTrials.gov ↗
Study Summary
Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments. This study will help hospitals across the US "stand up" new ways to evaluate stroke patients, decide who needs to be transferred, and transfer them quickly for advanced treatment.
Conditions Studied
Interventions
- BEHAVIORAL HI-SPEED Protocol
Study Locations (7)
Connecticut
- Yale New Haven Hospital — New Haven
Florida
- Jackson Memorial Hospital — Miami
Georgia
- Emory University Hospital — Atlanta
Illinois
- UChicago Medicine Ingalls Memorial Hospital — Chicago
New York
- New York Presbyterian - Weill Cornell Hospital — New York
Ohio
- University of Cincinnati Medical Center — Cincinnati
Utah
- University of Utah Health — Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06094478
The ClinicalTrials.gov registry entry for NCT06094478 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 846 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Stroke, Acute appearing as the primary indexed condition, and to 1 intervention — of which HI-SPEED Protocol is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06094478 reports 7 study locations spanning 7 distinct geographic areas — top geographies include Connecticut, Florida, Georgia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06094478 about?
NCT06094478 is a clinical study titled "Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition". Most stroke patients are initially evaluated at the closest hospital but some need to be transferred to a hospital that can provide more advanced care. The "Door-In-Door-Out" (DIDO) process at the first hospital can take time making transferred patients no longer able to get the advanced treatments....
What is the current status of trial NCT06094478?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2024-10-17. Estimated completion is 2028-07-31.
What conditions does trial NCT06094478 study?
This clinical trial studies the following conditions: Stroke, Acute, Hemorrhagic Stroke, Ischemic Stroke, Acute. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06094478?
The interventions under investigation include: HI-SPEED Protocol (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06094478?
This trial is sponsored by University of Chicago, which has 846 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06094478 being conducted?
This trial has 7 study locations across Connecticut, Florida, Georgia, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.